Genolution Statistics

Total Valuation

Genolution has a market cap or net worth of KRW 36.95 billion. The enterprise value is 30.73 billion.

Market Cap	36.95B
Enterprise Value	30.73B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Genolution has 18.07 million shares outstanding. The number of shares has decreased by -0.04% in one year.

Current Share Class	18.07M
Shares Outstanding	18.07M
Shares Change (YoY)	-0.04%
Shares Change (QoQ)	-0.95%
Owned by Insiders (%)	13.81%
Owned by Institutions (%)	n/a
Float	12.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.04
PB Ratio	0.50
P/TBV Ratio	0.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.81
EV / Sales	3.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.64

Financial Position

The company has a current ratio of 5.48, with a Debt / Equity ratio of 0.33.

Current Ratio	5.48
Quick Ratio	4.88
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	-2.85
Interest Coverage	-10.50

Financial Efficiency

Return on equity (ROE) is -11.32% and return on invested capital (ROIC) is -5.32%.

Return on Equity (ROE)	-11.32%
Return on Assets (ROA)	-5.18%
Return on Invested Capital (ROIC)	-5.32%
Return on Capital Employed (ROCE)	-9.31%
Revenue Per Employee	121.94M
Profits Per Employee	-107.45M
Employee Count	75
Asset Turnover	0.09
Inventory Turnover	2.15

Taxes

Income Tax	-245.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.07% in the last 52 weeks. The beta is 0.20, so Genolution's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	-6.07%
50-Day Moving Average	2,190.90
200-Day Moving Average	2,324.30
Relative Strength Index (RSI)	39.70
Average Volume (20 Days)	65,521

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genolution had revenue of KRW 9.15 billion and -8.06 billion in losses. Loss per share was -446.09.

Revenue	9.15B
Gross Profit	4.03B
Operating Income	-8.70B
Pretax Income	-9.07B
Net Income	-8.06B
EBITDA	-6.28B
EBIT	-8.70B
Loss Per Share	-446.09

Full Income Statement

Balance Sheet

The company has 29.98 billion in cash and 24.07 billion in debt, giving a net cash position of 5.91 billion or 327.26 per share.

Cash & Cash Equivalents	29.98B
Total Debt	24.07B
Net Cash	5.91B
Net Cash Per Share	327.26
Equity (Book Value)	73.39B
Book Value Per Share	4,094.14
Working Capital	28.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.23 billion and capital expenditures -1.20 billion, giving a free cash flow of -8.43 billion.

Operating Cash Flow	-7.23B
Capital Expenditures	-1.20B
Free Cash Flow	-8.43B
FCF Per Share	-466.84

Full Cash Flow Statement

Margins

Gross margin is 44.03%, with operating and profit margins of -95.09% and -88.12%.

Gross Margin	44.03%
Operating Margin	-95.09%
Pretax Margin	-99.18%
Profit Margin	-88.12%
EBITDA Margin	-68.67%
EBIT Margin	-95.09%
FCF Margin	n/a

Dividends & Yields

Genolution does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.04%
Shareholder Yield	0.04%
Earnings Yield	-21.81%
FCF Yield	-22.83%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 19, 2023. It was a forward split with a ratio of 2.

Last Split Date	Apr 19, 2023
Split Type	Forward
Split Ratio	2

Scores

Genolution has an Altman Z-Score of 1.86 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.86
Piotroski F-Score	3